SavedAdd your journal

Journals / Yeni Üroloji Dergisi / 2017 / Cilt: 12 - Sayı: 1

Medical treatment of male infertility

Erkek infertilitesinin medikal tedavisi

Ali ATAN
Fazlı POLAT
Süleyman YEŞİL
Ali ÜNSAL
Pages
58–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefor, specific treatment is given to infertile men who is found a specific reason while ampiric treatment is given to infertile men who is found no reason.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The reasons of male infertility are pretesticular, testicular and posttesticular.
📊
Key Findings & Data:Medical treatment is suitable for the men with infertility due to pretesticular and testicular reasons.
💡
Conclusion & Impact:Therefor, specific treatment is given to infertile men who is found a specific reason while ampiric treatment is given to infertile men who is found no reason.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:infertilite · erkek · medikal tedavi

Abstract

The reasons of male infertility are pretesticular, testicular and posttesticular. Medical treatment is suitable for the men with infertility due to pretesticular and testicular reasons. However, some of the infertile men may be found a reason while no reason is detected in some of infertile men. Therefor, specific treatment is given to infertile men who is found a specific reason while ampiric treatment is given to infertile men who is found no reason.

Özet

Erkek infertilitesinin nedenleri pretestiküler, testiküler ve posttestikülerdir. Medikal tedavi pretestiküler ve testiküler nedenlere bağlı infertilitesi olan erkeklerde uygundur. Ancak infertil erkeklerin bazılarında bir neden bulunabilir iken kalan bir kısmında belirli bir neden saptanamamaktadır. Bu nedenle infertil erkeklerin medikal tedavisinde altta yatan neden biliniyor ise ona yönelik spesifik bir tedavi uygulanır iken bir nedeninin bulunamadığı olgularda ampirik medikal tedaviler verilmektedir.

🔖

Cite This Article

ATAN, A., POLAT, F., YEŞİL, S., ÜNSAL, A. (2017). Medical treatment of male infertility. Yeni Üroloji Dergisi, Cilt: 12 - Sayı: 1, 58–62. https://ajindex.com/articles/337222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hamada A, Esteves SC, Nizza M, Agarwal A. Unexplained male infertility: diagnosis and management. Int Braz J Urol 2012; 38: 576-594
  2. Jung JH, Seo JT. Empirical medical therapy in idiopathic male infertility: Promise or panacea? Clin Exp Reprod Med 2014; 41: 108-114
  3. Dabaja AA, Schlegel PN. Medical treatment of male infertility. Trans Androl Urol 2014; 3: 9-16
  4. Garg H, Kumar R. Empirical Drug Therapy for Idiopathic Male Infertility: What is the New Evidence? Urology 2015; 86: 1065-1075
  5. Kumar R, Gautam G, Gupta NP. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 2006; 176:1307-1312
  6. Colacurci N, Monti MG, Fornaro F, et al. Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. J Androl 2012; 33: 588-593
  7. Attia AM, Abou-Setta AM, Al-Inany HG. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2013; 8:CD005071
  8. Jungwirth A, Diemer T, Dohle GR, Kopa Z, Krausz C, Tournaye H. The EAU Male Infertility Guidelines 2015
  9. Gregoriou O, Bakas P, Grigoriadis C, Creatsa M, Hassiakos D, Creatsas G. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. Fertil Steril 2012; 98: 48-51
  10. Clark RV, Sherins RJ. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl 1989; 10: 2:240-247
  11. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001;165: 837-41
  12. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002;167: 624-629
  13. Başar MM, Tuğlu D. Aromatase inhibitors in infertile patients: effects on seminal parameters, serum and seminal plasma testosterone levels, and estradiol levels during shortterm follow-up. Turk J Med Sci 2009; 39: 519-524
  14. Saylam B, Efesoy O, Cayan S. The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertil Steril 2011; 95: 809-811
  15. Cavallini G, Biagiotti G, Bolzon E. Multivariate analysis to predict letrozole efficacy in improving sperm count of nonobstructive azoospermic and cryptozoospermic patients: a pilot study. Asian J Androl 2011; 15: 806-811
  16. World Health Organization. A double-blind trial of c